Heptapeptide Ligands against Receptor-Binding Sites of Influenza Hemagglutinin toward Anti-Influenza Therapy

Publication date: Available online 21 January 2016
Source:Bioorganic & Medicinal Chemistry
Author(s): Teruhiko Matsubara, Ai Onishi, Daisuke Yamaguchi, Toshinori Sato
The initial attachment of influenza virus to cells is the binding of hemagglutinin (HA) to the sialyloligosaccharide receptor; therefore, the small molecules that inhibit the sugar-protein interaction are promising as HA inhibitors to prevent the infection. We herein demonstrate that sialic acid-mimic heptapeptides are identified through a selection from a primary library against influenza virus HA. In order to obtain lead peptides, an affinity selection from a phage-displayed random heptapeptide library was performed with the HAs of the H1 and H3 strains, and two kinds of the HA-binding peptides were identified. The binding of the peptides to HAs was inhibited in the presence of sialic acid, and plaque assays indicated that the corresponding N-stearoyl peptide strongly inhibited infections by the A/Aichi/2/68 (H3N2) strain of the virus. Alanine scanning of the peptides indicated that arginine and proline were responsible for binding. The affinities of several mutant peptides with single-amino-acid substitutions against H3 HA were determined, and corresponding docking studies were performed. A Spearman analysis revealed a correlation between the affinity of the peptides and the docking study. These results provide a practicable method to design of peptide-based HA inhibitors that are primising as anti-influenza drugs.

Graphical abstract

from #Medicine via ola Kala on Inoreader http://ift.tt/1PIS1y6
via IFTTT